Commentary

Article

State of the Science Summit - Bladder Cancer & RCC: Chaired by Bradley Somer, MD

State of the Science Summit - Bladder Cancer & RCC: Chaired by Bradley Somer, MD

State of the Science Summit - Bladder Cancer & RCC: Chaired by Bradley Somer, MD

Speakers

  • Bradley Somer, MD | West Cancer Center & Research Institute
  • Kathryn E. Beckermann, MD, PhD | Vanderbilt-Ingram Cancer Center
  • Holger L. Gieschen M.D | West Cancer Center & Research Institute
  • Nikhil Gopal, MD | University of Tennessee Health Science Center
  • Daniel Vaena, MD | West Cancer Center & Research Institute

Topics

  • How Do You Select Frontline Therapy in mUC?
  • R/R Urothelial Carcinoma: Second Line and Beyond
  • Case Review of mUC
  • How Do You Select Frontline TKI-Based Therapies for Advanced RCC?
  • Emerging Treatment Regimens for mRCC
  • Case Review of Advanced RCC

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Brian I. Rini, MD, FASCO
Marc Machaalani, MD
Razane El Hajj Chehade, MD
Antonio Cigliola, MD
Brian I. Rini, MD, FASCO
Karl Semaan, MD, MSc
Bradley McGregor, MD, discusses findings from a phase 1b study of abemaciclib  in clear cell renal cell carcinoma.
Toni K. Choueiri, MD
Neil J. Shah, MBBS
Sumanta Kumar Pal, MD, FASCO, chair, Kidney and Bladder Cancer Disease Team; co-director, Kidney Cancer Program; professor, vice chair, Academic Affairs, Department of Medical Oncology & Therapeutics Research, City of Hope